Fransvea E - Search Results

1

Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

Giannelli G, Bergamini C, Fransvea E, Marinosci F, Quaranta V, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Lab Invest. 2001 Apr;81(4):613-27. doi: 10.1038/labinvest.3780270. Lab Invest. 2001. PMID: 11304581 Free article.

2

Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma.

Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Int J Cancer. 2002 Feb 1;97(4):425-31. doi: 10.1002/ijc.1635. Int J Cancer. 2002. PMID: 11802202

3

Gelatinase levels in male and female breast cancer.

Giannelli G, Fransvea E, Marinosci F, Bergamini C, Daniele A, Colucci S, Paradiso A, Quaranta M, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Biochem Biophys Res Commun. 2002 Mar 22;292(1):161-6. doi: 10.1006/bbrc.2002.6599. Biochem Biophys Res Commun. 2002. PMID: 11890687

4

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Am J Pathol. 2002 Jul;161(1):183-93. doi: 10.1016/s0002-9440(10)64170-3. Am J Pathol. 2002. PMID: 12107103 Free PMC article.

5

Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma.

Giannelli G, Fransvea E, Bergamini C, Marinosci F, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3684-91. Clin Cancer Res. 2003. PMID: 14506159

6

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.

Fransvea E, Angelotti U, Antonaci S, Giannelli G. Fransvea E, et al. Hepatology. 2008 May;47(5):1557-66. doi: 10.1002/hep.22201. Hepatology. 2008. PMID: 18318443

7

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.

Fransvea E, Mazzocca A, Antonaci S, Giannelli G. Fransvea E, et al. Hepatology. 2009 Mar;49(3):839-50. doi: 10.1002/hep.22731. Hepatology. 2009. PMID: 19115199

8

HCC heterogeneity: molecular pathogenesis and clinical implications.

Fransvea E, Paradiso A, Antonaci S, Giannelli G. Fransvea E, et al. Cell Oncol. 2009;31(3):227-33. doi: 10.3233/CLO-2009-0473. Cell Oncol. 2009. PMID: 19478390 Free PMC article.

9

Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.

Santamato A, Fransvea E, Dituri F, Caligiuri A, Quaranta M, Niimi T, Pinzani M, Antonaci S, Giannelli G. Santamato A, et al. Among authors: fransvea e. Clin Sci (Lond). 2011 Aug;121(4):159-68. doi: 10.1042/CS20110002. Clin Sci (Lond). 2011. PMID: 21413933

10

Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.

Giannelli G, Azzariti A, Fransvea E, Porcelli L, Antonaci S, Paradiso A. Giannelli G, et al. Among authors: fransvea e. Br J Cancer. 2004 Nov 29;91(11):1964-9. doi: 10.1038/sj.bjc.6602231. Br J Cancer. 2004. PMID: 15545972 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters